Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 90 | 0 | 81 | 1,030 | 1,144 |
| Gross Profit | 90 | N/A | 81 | 1,030 | 1,144 |
| Operating Expenses | 36,337 | 42,121 | 52,001 | 35,134 | 26,108 |
| Operating Income | -36,247 | -42,121 | -51,920 | -34,104 | -24,964 |
| Other Income | 2,360 | 3,878 | 3,102 | 1,087 | 190 |
| Pre-tax Income | -33,887 | -38,243 | -48,818 | -33,017 | -24,774 |
| Net Income Continuous | -33,887 | -38,243 | -48,818 | -33,017 | -24,774 |
| Net Income | $-33,887 | $-38,243 | $-48,818 | $-33,017 | $-24,774 |
| EPS Basic Total Ops | -1.09 | -1.27 | -1.83 | -1.37 | -1.20 |
| EPS Basic Continuous Ops | -1.09 | -1.27 | -1.84 | -1.37 | -1.20 |
| EPS Diluted Total Ops | -1.09 | -1.27 | -1.83 | -1.37 | -1.20 |
| EPS Diluted Continuous Ops | -1.09 | -1.27 | -1.84 | -1.37 | -1.20 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.27 | -1.83 | -1.37 | N/A |
| EBITDA(a) | $-35,426 | $-41,310 | $-51,130 | $-33,405 | $-24,440 |